Skip to content

Hypertonic Saline Resuscitation in Trauma Patients After Hemorrhage Control

Hypertonic Saline Resuscitation for Early Closure of Open Abdomen in Trauma Patients

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02542241
Acronym
CELTA
Enrollment
52
Registered
2015-09-04
Start date
2015-11-27
Completion date
2018-09-04
Last updated
2020-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Injuries

Keywords

Open abdomen, hypertonic saline solution, intensive care

Brief summary

This study aimed to determine whether hypertonic saline solution is effective in the resuscitation of injured patients undergoing abdominal damage control surgery regarding early closure of the abdominal wall.

Detailed description

A double-blind, controlled, randomized clinical trial was conducted to determine the impact of an infusion of hypertonic saline 3% vs. isotonic saline 0.9% at a dose of 50 mL/hr for the first 72 hours in patients with abdominal trauma requiring damage control surgery regarding some clinically relevant outcomes. These outcomes were: The timing of abdominal cavity closure, fluids balance, abdominal hypertension, and abdominal compartment syndrome occurrence, organ dysfunction, and 28 days' mortality.

Interventions

DRUGSodium Chloride [3%]

Patients in this arm will receive an intravenous infusion of 3% hypertonic saline at a 50 cc/hour rate, which will be administered by an infusion pump during the first 72 hours after the damage control surgery. A total of 3600cc will be administered throughout 72 hours ( 1200cc every 24 hours).

DRUGSodium Chloride [0.9%]

Patients in this arm will receive an intravenous infusion of 0.9% hypertonic saline at a 50 cc/hour rate, which will be administered by an infusion pump during the first 72 hours after the damage control surgery. A total of 3600cc will be administered throughout 72 hours ( 1200cc every 24 hours).

Sponsors

Fundacion Clinica Valle del Lili
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Abdominal trauma requiring damage control surgery. * Acceptance by the patient or by a proxy to be included in the trial.

Exclusion criteria

* Concomitant severe head trauma, defined by a Glasgow score \<9, before receiving sedation or by the presence of cerebral edema or intracranial injury on a CT-scan. * Pregnancy * Patient not included 4 hours or more after damage control surgery. * Damage control laparotomy performed for other indications other than trauma. * Not index damage control laparotomy * No acceptance to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Abdominal wall closure7 daysProportion of patients in which closure of abdominal wall was achieved in the first 7 days after injury.

Secondary

MeasureTime frameDescription
Fluid Balance measured in cm372 hoursFluid balance during the first 72 hours after injury. Defined as the difference between the amount of fluids taken into the body and the amount excreted or lost. Input includes oral fluids, infused intravenous fluids and blood products. Output includes fluid loss as urine, emesis and wound drainage among others.
Incidence of Abdominal compartment syndrome7 daysIncidence of abdominal compartment syndrome (defined as sustained intra-abdominal pressure \> 20 mmHg, accompanied by new organ dysfunction, defined as a score \> 2, under the SOFA scale compromising lung, kidney, or heart) during the first 7 days after injury.
Incidence of Organ Failure7 daysIncidence of organ failure (defined as SOFA score greater than 2).
Mortality28 days28 day mortality rate

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026